लोड हो रहा है...
Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance?
Helicobacter pylori (H. pylori) antimicrobial resistance is an urgent, global issue. In 2017, the World Health Organization designated clarithromycin-resistant H. pylori as a high priority bacterium for antibiotic research and development. In addition to clarithromycin, resistance to metronidazole a...
में बचाया:
| में प्रकाशित: | World J Gastroenterol |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Baishideng Publishing Group Inc
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487377/ https://ncbi.nlm.nih.gov/pubmed/31086459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i16.1907 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|